These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 11209286)

  • 21. Long-term outcome of quetiapine use for psychosis among Parkinsonian patients.
    Fernandez HH; Trieschmann ME; Burke MA; Jacques C; Friedman JH
    Mov Disord; 2003 May; 18(5):510-4. PubMed ID: 12722164
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quetiapine-induced dystonia and agitation in Parkinson's disease with dementia: a case report.
    Leey J; Setters B; Murphy P; Antimisiaris D; Miles T
    J Am Geriatr Soc; 2009 May; 57(5):918-9. PubMed ID: 19470011
    [No Abstract]   [Full Text] [Related]  

  • 23. Quetiapine treatment for behavioural and psychological symptoms of dementia in Alzheimer's disease patients: a 6-week, double-blind, placebo-controlled study.
    Paleacu D; Barak Y; Mirecky I; Mazeh D
    Int J Geriatr Psychiatry; 2008 Apr; 23(4):393-400. PubMed ID: 17879256
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Psychosis in Parkinson's disease: case studies.
    Salter BC; Anderson KE; Weiner WJ
    Neurol Clin; 2006 May; 24(2):363-9. PubMed ID: 16684637
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The neurochemical mechanism of rebound psychosis in Parkinson's disease.
    Papapetropoulos S; Mash DC
    Mov Disord; 2005 Apr; 20(4):515. PubMed ID: 15747367
    [No Abstract]   [Full Text] [Related]  

  • 26. Rater-blinded, prospective comparison: quetiapine versus clozapine for Parkinson's disease psychosis.
    Merims D; Balas M; Peretz C; Shabtai H; Giladi N
    Clin Neuropharmacol; 2006; 29(6):331-7. PubMed ID: 17095896
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Evidence-based treatment of psychosis associated with Parkinson's disease].
    Haussmann R; Bauer M; Donix M
    Nervenarzt; 2016 May; 87(5):543-51. PubMed ID: 26643499
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Melperone is ineffective in treating Parkinson's disease psychosis.
    Friedman JH
    Mov Disord; 2012 May; 27(6):803-4. PubMed ID: 22362330
    [No Abstract]   [Full Text] [Related]  

  • 29. Risperidone for psychosis of Alzheimer's disease and mixed dementia: results of a double-blind, placebo-controlled trial.
    Brodaty H; Ames D; Snowdon J; Woodward M; Kirwan J; Clarnette R; Lee E; Greenspan A
    Int J Geriatr Psychiatry; 2005 Dec; 20(12):1153-7. PubMed ID: 16315159
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effect of quetiapine fumarate on drug-induced psychosis in patients with Parkinson's disease].
    Kohmoto J; Kihira T; Miwa H; Kondo T
    No To Shinkei; 2002 Jun; 54(6):489-92. PubMed ID: 12166098
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and tolerability of quetiapine in the treatment of behavioral and psychological symptoms of dementia.
    Onor ML; Saina M; Aguglia E
    Am J Alzheimers Dis Other Demen; 2006 Dec-2007 Jan; 21(6):448-53. PubMed ID: 17267378
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Psychosis in Parkinson's disease: how should we treat it?
    Shotbolt P; Samuel M; Anthony D
    Expert Rev Neurother; 2006 Sep; 6(9):1243-6. PubMed ID: 17009911
    [No Abstract]   [Full Text] [Related]  

  • 33. Repeated occurrence of clozapine-induced myocarditis in a patient with schizoaffective disorder and comorbid Parkinson's disease.
    Masopust J; Urban A; Valis M; Malý R; Tůma I; Hosák L
    Neuro Endocrinol Lett; 2009 Mar; 30(1):19-21. PubMed ID: 19300384
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Treatment of Parkinson's disease associated with psychosis].
    Ombrato M; Capone D
    Clin Ter; 1975 Aug; 74(3):293-7. PubMed ID: 1227749
    [No Abstract]   [Full Text] [Related]  

  • 35. Management of neurodegenerative disorders: Parkinson's disease and Alzheimer's disease.
    Pal PK; Netravathi M
    J Indian Med Assoc; 2005 Mar; 103(3):168-70, 172, 174-6. PubMed ID: 16173294
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Chorea following withdrawal of quetiapine].
    Jiménez-Caballero PE; Velázquez-Pérez JM; Marsal-Alonso C; Alvarez-Tejerina A
    Rev Neurol; 2004 Jun 1-15; 38(11):1094. PubMed ID: 15202092
    [No Abstract]   [Full Text] [Related]  

  • 37. [Effects of quetiapine at low doses on psychosis motor disability and stress of the caregiver in patients with Parkinson's disease].
    Giménez-Roldán S; Navarro E; Mateo D
    Rev Neurol; 2003 Mar 1-15; 36(5):401-4. PubMed ID: 12640589
    [TBL] [Abstract][Full Text] [Related]  

  • 38. FDA user fee may speed approval of Alzheimer's, Parkinson's drugs.
    Geriatrics; 1992 Dec; 47(12):15-6. PubMed ID: 1446840
    [No Abstract]   [Full Text] [Related]  

  • 39. The efficacy and safety of quetiapine for treatment of geriatric psychosis.
    Yang CH; Tsai SJ; Hwang JP
    J Psychopharmacol; 2005 Nov; 19(6):661-6. PubMed ID: 16272189
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of drug-induced psychosis in Parkinson's disease with ziprasidone can induce severe dose-dependent off-periods and pathological laughing.
    Schindehütte J; Trenkwalder C
    Clin Neurol Neurosurg; 2007 Feb; 109(2):188-91. PubMed ID: 16949733
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.